Abdelgawad MA

References (4)

Title : Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation - Kumar_2023_RSC.Adv_13_9513
Author(s) : Kumar S , Manoharan A , J J , Abdelgawad MA , Mahdi WA , Alshehri S , Ghoneim MM , Pappachen LK , Zachariah SM , Aneesh TP , Mathew B
Ref : RSC Adv , 13 :9513 , 2023
Abstract : Kumar_2023_RSC.Adv_13_9513
ESTHER : Kumar_2023_RSC.Adv_13_9513
PubMedSearch : Kumar_2023_RSC.Adv_13_9513
PubMedID: 36968055

Title : MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease - Sasidharan_2023_Neurochem.Res__
Author(s) : Sasidharan R , Mohanan R , Kukreti N , Raj P , Abdelgawad MA , Ghoneim MM , Manju SL , Mathew B
Ref : Neurochem Res , : , 2023
Abstract : Sasidharan_2023_Neurochem.Res__
ESTHER : Sasidharan_2023_Neurochem.Res__
PubMedSearch : Sasidharan_2023_Neurochem.Res__
PubMedID: 37814132

Title : Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations - Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
Author(s) : Sasidharan R , Eom BH , Heo JH , Park JE , Abdelgawad MA , Musa A , Gambacorta N , Nicolotti O , Manju SL , Mathew B , Kim H
Ref : J Enzyme Inhib Med Chem , 36 :188 , 2021
Abstract : Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
ESTHER : Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
PubMedSearch : Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
PubMedID: 33430657

Title : Halogenated Coumarin-Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors - Rehuman_2021_ACS.Omega_6_28182
Author(s) : Rehuman NA , Oh JM , Nath LR , Khames A , Abdelgawad MA , Gambacorta N , Nicolotti O , Jat RK , Kim H , Mathew B
Ref : ACS Omega , 6 :28182 , 2021
Abstract : Rehuman_2021_ACS.Omega_6_28182
ESTHER : Rehuman_2021_ACS.Omega_6_28182
PubMedSearch : Rehuman_2021_ACS.Omega_6_28182
PubMedID: 34723016